LOBAPLATIN for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 19 adverse event reports in the FDA FAERS database where LOBAPLATIN was used for Lung neoplasm malignant.
Most Reported Side Effects for LOBAPLATIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 84 | 42.2% | 1 | 50 |
| White blood cell count decreased | 21 | 10.6% | 0 | 12 |
| Platelet count decreased | 17 | 8.5% | 1 | 11 |
| Off label use | 15 | 7.5% | 1 | 8 |
| Nausea | 14 | 7.0% | 1 | 5 |
| Neutrophil count decreased | 14 | 7.0% | 0 | 7 |
| Bone marrow failure | 12 | 6.0% | 0 | 5 |
| Vomiting | 11 | 5.5% | 1 | 5 |
| Hepatic function abnormal | 10 | 5.0% | 0 | 1 |
| Rash | 10 | 5.0% | 0 | 3 |
| Asthenia | 9 | 4.5% | 1 | 3 |
| Diarrhoea | 9 | 4.5% | 2 | 3 |
| Anaemia | 8 | 4.0% | 0 | 2 |
| Gastrointestinal disorder | 8 | 4.0% | 0 | 0 |
| Pyrexia | 8 | 4.0% | 0 | 6 |
Other Indications for LOBAPLATIN
Hepatocellular carcinoma (16)
Breast cancer (12)
Ovarian cancer (12)
Lung adenocarcinoma (11)
Oesophageal carcinoma (10)
Adenocarcinoma (9)
Chemotherapy (7)
Oesophageal squamous cell carcinoma (5)
Serous cystadenocarcinoma ovary (5)
Small cell lung cancer (5)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)